Fortrea Holdings (FTRE) Other Working Capital Changes (2022 - 2026)

Fortrea Holdings' (FTRE) quarterly Other Working Capital Changes came in at $22.1 million in Q2 2026, up 72.66% YoY from $12.8 million in Q2 2025, and up 234.85% on a QoQ basis from $6.6 million in Q1 2026.

Fortrea Holdings (FTRE) Other Working Capital Changes (2022 - 2026) Analysis & Trends

Fortrea Holdings (FTRE) has 5 years of Other Working Capital Changes data on file, last reported at $22.1 million in Q2 2026.

  • Quarterly Other Working Capital Changes rose 72.66% year-over-year to $22.1 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $120.3 million (down 6.74% YoY) and the FY2025 annual result came in at $114.8 million, down 18.0% from the prior year.
  • Other Working Capital Changes climbed to $22.1 million in Q2 2026, from $6.6 million in the prior quarter.
  • In the past five years, Other Working Capital Changes ranged from a high of $44.8 million in Q4 2024 to a low of -$19.3 million in Q3 2025.
  • A 5-year average of $2.0 million and a median of -$3.9 million in 2022 frame the typical range for Other Working Capital Changes.
  • Annual changes were most pronounced in 2024 — Other Working Capital Changes soared 14540.0% — and 2025, when it plunged 60.61%.
  • Tracing FTRE's Other Working Capital Changes over 5 years: stood at $8.2 million in 2022, then plunged by 53.66% to $3.8 million in 2023, then jumped by 784.21% to $33.6 million in 2024, then soared by 79.17% to $60.2 million in 2025, then sank by 63.29% to $22.1 million in 2026.
  • The last three Other Working Capital Changes figures came in at $22.1 million (Q2 2026), $6.6 million (Q1 2026), and $60.2 million (Q4 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn
4 Revolution Medicines 43.64 Bn 43.64 Bn -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn
7 Royalty Pharma 33.72 Bn 35.84 Bn -
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn
10 Fortrea Holdings 1.66 Bn 1.49 Bn 139.20 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 -6.10 Mn
Jun 30, 2026 -6.10 Mn
Jun 30, 2026 -6.10 Mn
Mar 31, 2026 -11.40 Mn
Mar 31, 2026 -11.40 Mn
Mar 31, 2026 -11.40 Mn
Dec 31, 2025 11.40 Mn
Dec 31, 2025 11.40 Mn
Dec 31, 2025 11.40 Mn
Sep 30, 2025 -19.30 Mn
Sep 30, 2025 -19.30 Mn
Sep 30, 2025 -19.30 Mn
Jun 30, 2025 -6.90 Mn
Jun 30, 2025 -6.90 Mn
Jun 30, 2025 -6.90 Mn
Mar 31, 2025 -17.60 Mn
Mar 31, 2025 -17.60 Mn
Mar 31, 2025 -17.60 Mn
Dec 31, 2024 44.80 Mn
Dec 31, 2024 44.80 Mn